Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Johannes Frasez Sørensen, Anni Aggerholm, Marcus H Hansen, MSc, Gitte Birk Kerndrup, MD DMSc, Lene Hyldahl Ebbesen, MD PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD, Maja Ludvigsen, MSc, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141993

Published: 2020

Journal Articles

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Johannes Frasez Soerensen, Anni Aggerholm, MSc, PhD, Gitte Birk Kerndrup, MD DMSc, Marcus C Hansen, MSc, Ina Kathrine Lykke Ewald, Lene Hyldahl Ebbesen, MD PhD, Carina A Rosenberg, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD Ass. Prof, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2018-99-114482

Published: 2018

Journal Articles

Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma

Hanne Due, MSc, Anna Amanda Schönherz, PhD, Laura Barett Ryø, MSc, Anne Stidsholt Roug, MD Ass. Prof, Hans Erik Johnsen, MD Professor, Martin Bøgsted, Professor, Jacob Giehm Mikkelsen, Prof, Karen Dybkær, Professor

Blood (2017) 130 (Supplement 1): 2838.

https://doi.org/10.1182/blood.V130.Suppl_1.2838.2838

Published: 2017

Journal Articles

RNA-Sequencing of Cytogenetically Normal Acute Myeloid Leukemia to Extend Routine Molecular Diagnostics

Laura Laine Herborg, MD fellow, Marcus Celik Hansen, MSc in Biomedical Engineering, Maria Hansen, MSc, PhD, Anne Stidsholt Roug, MD PhD, Peter Hokland, MDD.MDSci, Professor

Blood (2015) 126 (23): 4969.

https://doi.org/10.1182/blood.V126.23.4969.4969

Published: 2015

Journal Articles

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

Marcus Celik Hansen, MSc in Biomedical Engineering, Charlotte Guldborg Nyvold, MSc, PhD, Anne Stidsholt Roug, MD PhD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1979.

https://doi.org/10.1182/blood.V124.21.1979.1979

Published: 2014

Journal Articles

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Marie Toft-Petersen, MD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD

Blood (2014) 124 (21): 3235.

https://doi.org/10.1182/blood.V124.21.3235.3235

Published: 2014

Journal Articles

Relevance of sCD163 As a Prognostic Biomarker in Chronic B-Cell Lymphocytic Leukemia

Line Nederby, MSc, PhD, Anne Stidsholt Roug, MD PhD, Signe Schöllhammer Knudsen, MD, Holger Jon Moller, MD PhD, Anni Skovbo, Marianne Hokland, MD DSc

Blood (2014) 124 (21): 5643.

https://doi.org/10.1182/blood.V124.21.5643.5643

Published: 2014

Journal Articles

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Peter Buur van Kooten Niekerk, MD, Charlotte Christie Petersen, MSc PhD, Charlotte Guldborg Nyvold, MSc, PhD, Hans Beier Ommen, MD, PhD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Eigil Kjeldsen

Blood (2013) 122 (21): 1501.

https://doi.org/10.1182/blood.V122.21.1501.1501

Published: 2013

Journal Articles

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Charlotte Christie Petersen, MSc PhD, Line Nederby, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Ole Weis Bjerrum, MD, Andreja Dimitrijevic, MD, Marianne T. Severinsen, MD, PhD, Jesper Stentoft, MD, PhD, Peter Hokland, MD, DMSC

Blood (2013) 122 (21): 2704.

https://doi.org/10.1182/blood.V122.21.2704.2704

Published: 2013

Journal Articles

Two Hematological Pre-Malignancies In a Pair Of Homozygous Twins Revealing Differences In Their Pre- and Postnatal Development

Peter Hokland, M.D. D. Med. Sci., Anne Stidsholt Roug, MD, Line Nederby, MSc, PhD, Eigil Kjeldsen, MD, Palle Villesen, M.Sc. Ph.D., Charlotte Guldborg Nyvold, MSc, PhD

Blood (2013) 122 (21): 5262.

https://doi.org/10.1182/blood.V122.21.5262.5262

Published: 2013

Journal Articles

Unraveling The Leukemic Nature Of hMICL and CD123 Expressing Cells In Acute Myeloid Leukemia

Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Gordon Brown, MSc, PhD, Maria Hansen, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Anne Stidsholt Roug, MD, PhD

Blood (2013) 122 (21): 2626.

https://doi.org/10.1182/blood.V122.21.2626.2626

Published: 2013

Journal Articles

Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms

Line Nederby, MSc, PhD, Laura Laine Larsen, Peter Hokland, MD, DMSC, Anne Stidsholt Roug, MD, PhD

Blood (2012) 120 (21): 1724.

https://doi.org/10.1182/blood.V120.21.1724.1724

Published: 2012

Journal Articles

Poor Mobilizers in an Autologous Hematopoietic Stem Cell Transplantation Setting: Matched Pair Analysis Profiling G-CSF and Plerixafor-Mobilized Stem Cells

Line Nederby, MSc, PhD, Lea Bjerre Hokland, MSc, PhD, Katrine Nielsen, MD, Erik Kay Segel, MD, Peter Hokland, MD, DMSC, Anne Stidsholt Roug, MD, PhD

Blood (2012) 120 (21): 4413.

https://doi.org/10.1182/blood.V120.21.4413.4413

Published: 2012

Journal Articles

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Charlotte Christie Petersen, MSc, Hans Beier Ommen, MD, PhD, Eigil Kjeldsen, MD, Knud Bendix, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD, DMSC

Blood (2012) 120 (21): 4427.

https://doi.org/10.1182/blood.V120.21.4427.4427

Published: 2012

Journal Articles

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Anne Stidsholt Roug, MD, Hanne Oestergaard Larsen, PhD, MSc,, Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC

Blood (2011) 118 (21): 1447.

https://doi.org/10.1182/blood.V118.21.1447.1447

Published: 2011

Journal Articles

CD34+ SSC lo ALDH br – a New Marker for Improved Characterization of Poor Myeloid Regeneration in the Autologous Hematopoietic Transplantation Setting?,

Katrine Nielsen, Lea Bjerre, PhD, BSc, MSc,, Hanne Oestergaard Larsen, PhD, MSc,, Peter Hokland, Sr., M.D., D., Med., Sci., Anne Stidsholt Roug, MD

Blood (2011) 118 (21): 4007.

https://doi.org/10.1182/blood.V118.21.4007.4007

Published: 2011

Journal Articles

A New Protocol for Efficient and Non-Toxic Transfection of siRNA Into Leukemic Cell Lines and Primary Cells – a Direct Comparison Between Nucleofection and Accell Delivery Using Stem Cell Related Antigens As Validation Tools

Hanne Østergaard Larsen, MSci, PhD, Anne Stidsholt Roug, MD, Claus Svane Sondergaard, MSci, PhD, Peter Hokland, MD, DMSC

Blood (2011) 118 (21): 4802.

https://doi.org/10.1182/blood.V118.21.4802.4802

Published: 2011

Journal Articles

Flow Cytometric Detection of Minimal Residual Disease In Acute Myeloid Leukemia – the Addition of hMICL and CD123 Add to Sensitivity and Applicability

Anne Stidsholt Roug, MD, Jan A. Nolta, PhD, Hanne Oestergaard Larsen, Claus Sondergaard, Ph.D, Peter Hokland, MD, DMSC

Blood (2010) 116 (21): 2719.

https://doi.org/10.1182/blood.V116.21.2719.2719

Published: 2010

NARROW

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma

RNA-Sequencing of Cytogenetically Normal Acute Myeloid Leukemia to Extend Routine Molecular Diagnostics

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Relevance of sCD163 As a Prognostic Biomarker in Chronic B-Cell Lymphocytic Leukemia

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Two Hematological Pre-Malignancies In a Pair Of Homozygous Twins Revealing Differences In Their Pre- and Postnatal Development

Unraveling The Leukemic Nature Of hMICL and CD123 Expressing Cells In Acute Myeloid Leukemia

Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms

Poor Mobilizers in an Autologous Hematopoietic Stem Cell Transplantation Setting: Matched Pair Analysis Profiling G-CSF and Plerixafor-Mobilized Stem Cells

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

CD34+ SSC lo ALDH br – a New Marker for Improved Characterization of Poor Myeloid Regeneration in the Autologous Hematopoietic Transplantation Setting?,

A New Protocol for Efficient and Non-Toxic Transfection of siRNA Into Leukemic Cell Lines and Primary Cells – a Direct Comparison Between Nucleofection and Accell Delivery Using Stem Cell Related Antigens As Validation Tools

Flow Cytometric Detection of Minimal Residual Disease In Acute Myeloid Leukemia – the Addition of hMICL and CD123 Add to Sensitivity and Applicability

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only